Form 4: Elanco Animal Health Executive Reports Stock Transactions
SEC Form 4 Filing
Jose Manuel Correia de Simas, an Executive Vice President at Elanco Animal Health, reported the acquisition and disposal of company stock on February 19, 2025.
Summary
- On February 19, 2025, Jose Manuel Correia de Simas, an Executive Vice President at Elanco Animal Health Inc., reported transactions involving the company's common stock.
- He acquired 26,082 shares of common stock at $0.
- He disposed of 11,808 shares of common stock at $11.24.
- Following these transactions, he directly owns 64,042 shares of Elanco Animal Health Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing, so the sentiment is neither positive nor negative.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, as required by the SEC. It provides transparency into the actions of company insiders.
Key Dates
| Date | Description |
|---|---|
| May 14, 2024 | Date of Power of Attorney grant. |
| 02/19/2025 | Date of stock acquisition and disposal. |
| 02/21/2025 | Date of signature on the Form 4 filing. |
Keywords
Elanco Animal Health, Stock Transactions, Form 4, Insider Trading, Executive Vice President, Jose Manuel Correia de Simas, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.